News
TaiGen Biotechnology Announces Submission of New Drug Application for ...
16 May 2013
TAIPEI, Taiwan, May 16, 2013 ? /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they have submitted New Drug Application (NDA) for the oral formulation of nemonoxacin with the Taiwan Food and Drug ...
Click on the link to read the full article at The Herald | HeraldOnline.com (This link will open in a new window)TaiGen Biotechnology Announces Submission of New Drug Application for ...
16 May 2013
TAIPEI, Taiwan, May 16, 2013 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they have submitted New Drug Application (NDA) for the oral formulation of nemonoxacin with the Taiwan Food and Drug ...
Click on the link to read the full article at PR Newswire (press release) (This link will open in a new window)Communist Germany allowed Western pharmaceutical firms testes new drugs in ...
16 May 2013
Western pharmaceutical firms allegedly conducted drug tests on unwitting patients in communist East Germany. The lucrative clinical trials enabled the GDR government to bring much needed hard currency according to a report from Deutsche Welle.
Click on the link to read the full article at MercoPress (This link will open in a new window)7 Biotechnology Stocks to Sell Now
15 May 2013
The overall ratings of seven Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a ?D? (?sell?) or ?F? overall (?strong sell?). Genomic Health (NASDAQ:GHDX) is on the decline this week, earning a D (?sell?) after receiving ...
Click on the link to read the full article at Investorplace.com (This link will open in a new window)Gay Byrne launches generics campaign
15 May 2013
Gay Byrne launches generics campaign. Comments. Email; Print; Font Size. Gay Byrne has helped to launch a generics campaign to coincide with a new law on affordable medicines. Download our Free iPhone App Now · Download our Free Android App ...
Click on the link to read the full article at Irish Independent (This link will open in a new window)5 Biotechnology Stocks to Buy Now
15 May 2013
Five Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an ?A? (?strong buy?) or ?B? overall (?buy?). This week, Ariad Pharmaceuticals (NASDAQ:ARIA) is showing ...
Click on the link to read the full article at Investorplace.com (This link will open in a new window)Plandai Biotechnology, Inc. Announces Positive Anti-Malaria Test Results Using ...
15 May 2013
SEATTLE, May 15, 2013 /PRNewswire/ -- Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical and pharmaceutical, today announced that the Company's ...
Click on the link to read the full article at PR Newswire (press release) (This link will open in a new window)Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for ...
15 May 2013
Teva Pharmaceutical Industries Limited ( TEVA ) will begin trading ex-dividend on May 16, 2013. A cash dividend payment of $0.32 per share is scheduled to be paid on June 03, 2013. Shareholders who purchased TEVA stock prior to the ex-dividend date ...
Click on the link to read the full article at NASDAQ (This link will open in a new window)United States Opens Pharmaceutical Advancement Centre In Ghana
15 May 2013
The United States (US) Pharmacopeial Convention (USP) has launched the Center for Pharmaceutical Advancement and Training (CePAT) in Accra as part of efforts to increase the number of experts and available tools to combat falsified, substandard and ...
Click on the link to read the full article at Ghana (This link will open in a new window)Center for Pharmaceutical Advancement and Training Opens in Ghana
15 May 2013
In an effort to increase the number of experts and available tools to combat falsified, substandard and counterfeit medicines in countries in Sub-Saharan Africa, the U.S. Pharmacopeial Convention (USP) has launched the Center for Pharmaceutical ...
Click on the link to read the full article at AllAfrica.com (This link will open in a new window)
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
